Cargando…

Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval

BACKGROUND: Mesenchymal stromal cells (MSCs) may reduce mortality in patients with COVID-19; however, early evidence is based on few studies with marked interstudy heterogeneity. The second iteration of our living systematic review and meta-analysis evaluates a framework needed for synthesizing evid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirkham, Aidan M, Bailey, Adrian J M, Monaghan, Madeline, Shorr, Risa, Lalu, Manoj M, Fergusson, Dean A, Allan, David S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Human Clinical Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299509/ https://www.ncbi.nlm.nih.gov/pubmed/35758400 http://dx.doi.org/10.1093/stcltm/szac038

Ejemplares similares

Mesenchymal Stromal Cells As a Therapeutic Intervention for COVID-19: Second Iteration of a Living Systematic Review and Meta-Analysis
por: Kirkham, Aidan, et al.
Publicado: (2022)

Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
por: Kirkham, Aidan M., et al.
Publicado: (2021)

Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19
por: Kirkham, Aidan M., et al.
Publicado: (2022)

Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
por: Kirkham, Aidan M., et al.
Publicado: (2023)

MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: a Systematic Review and Meta-Analysis of Preclinical Animal Studies
por: Bailey, Adrian J. M., et al.
Publicado: (2021)

A Portrait of Sars-Cov-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature
por: Bailey, Adrian, et al.
Publicado: (2022)

A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature
por: Bailey, Adrian J. M., et al.
Publicado: (2022)

Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol
por: Tieu, Alvin, et al.
Publicado: (2019)

A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence—FAST Evidence
por: Liao, Gary, et al.
Publicado: (2020)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence)
por: Zheng, Katina, et al.
Publicado: (2020)

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022)

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021)

Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
por: Wilson, Brooke E., et al.
Publicado: (2021)

Ethics Approval
por: Ross, W M
Publicado: (1994)

Approved Criminality
por: Consley, J. M.
Publicado: (1892)

An update on the novel and approved drugs for Alzheimer disease
por: Alhazmi, Hassan Ahmad, et al.
Publicado: (2022)

Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)
por: Thébaud, Bernard, et al.
Publicado: (2021)

Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU
por: Demirci, Ebru, et al.
Publicado: (2023)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
por: Lalu, Manoj M., et al.
Publicado: (2012)

Definition and Characteristics of Mesenchymal Stromal Cells in Preclinical and Clinical Studies: A Scoping Review
por: Renesme, Laurent, et al.
Publicado: (2022)

FDA Coronavirus Treatment Acceleration Program: approved drugs and those in clinical trials
por: Nainwal, Lalit Mohan, et al.
Publicado: (2022)

An update on the clinical evidence that supports biosimilar approvals in Europe
por: Mielke, Johanna, et al.
Publicado: (2018)

Feds update immunization advice with Moderna vaccine approval
por: Vogel, Lauren
Publicado: (2021)

Contezolid: First Approval
por: Hoy, Sheridan M.
Publicado: (2021)

Deucravacitinib: First Approval
por: Hoy, Sheridan M.
Publicado: (2022)

The Vaccination Papers Approved
por: Dillingham, Thomas M.
Publicado: (1898)

Rozanolixizumab: First Approval
por: Hoy, Sheridan M.
Publicado: (2023)

Elacestrant: First Approval
por: Hoy, Sheridan M.
Publicado: (2023)

Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta‐analysis of preclinical studies
por: Maganti, Harinad B., et al.
Publicado: (2021)

Winning approval
por: Schopper, Herwig Franz
Publicado: (2004)

Approved Minutes
Publicado: (2010)

Approved Minutes
Publicado: (2010)

Approved Minutes
Publicado: (2011)

Approved Minutes
Publicado: (2009)

Approved Minutes
Publicado: (2008)

Approval voting
por: Brams, Steven J, et al.
Publicado: (2007)

Seek success, not approval: the only approval you need is yours
por: Elko, Kevin, et al.
Publicado: (2010)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oii5aj73p3a5vcf9s6o4afnrqr